A Novel Magnetically Targeted Intramedullary (MagIC-TI) Xenograft Model for Precise Leukemia Modeling and Drug Resistance Evaluation in the Bone Marrow Niche.

Synribo (omacetaxine mepesuccinate) - Teva

doxorubicin hydrochloride - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/42365463

Jiabao Wu; Jiawei Rong; Jiaxing Zhang; Jingyi Guo; Lihan Dai; Lingxi Chen; Luxia Tang; Qianli Jiang; Qiusui Mai; Siyi Li; Taosong Liu; Weishen Zhang; Wen Xia; Xiaojun Xu

Jun 29, 2026